$NEO
NEOGENOMICS INC

2015 Q1 Form 10-Q Financial Statement

#000119312515181991 Filed on May 11, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $23.03M $18.18M
YoY Change 26.64% 16.13%
Cost Of Revenue $13.48M $9.473M
YoY Change 42.32% 12.63%
Gross Profit $9.544M $8.709M
YoY Change 9.59% 20.19%
Gross Profit Margin 41.45% 47.9%
Selling, General & Admin $9.436M $7.687M
YoY Change 22.75% 25.89%
% of Gross Profit 98.87% 88.27%
Research & Development $669.0K $628.0K
YoY Change 6.53% -24.79%
% of Gross Profit 7.01% 7.21%
Depreciation & Amortization $1.586M $1.151M
YoY Change 37.79% 16.26%
% of Gross Profit 16.62% 13.22%
Operating Expenses $10.11M $8.315M
YoY Change 21.53% 19.8%
Operating Profit -$561.0K $394.0K
YoY Change -242.39% 29.18%
Interest Expense -$200.0K $265.0K
YoY Change -175.47% -7.02%
% of Operating Profit 67.26%
Other Income/Expense, Net -$195.0K -$265.0K
YoY Change -26.42%
Pretax Income -$756.0K $129.0K
YoY Change -686.05% 545.0%
Income Tax $5.000K $27.00K
% Of Pretax Income 20.93%
Net Earnings -$761.0K $102.0K
YoY Change -846.08% 3300.0%
Net Earnings / Revenue -3.3% 0.56%
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 60.28M 49.28M
Diluted Shares Outstanding 60.28M 53.47M

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.20M $5.400M
YoY Change 477.78% 17.39%
Cash & Equivalents $31.25M $5.385M
Short-Term Investments
Other Short-Term Assets $2.000M $1.500M
YoY Change 33.33% 87.5%
Inventory $2.595M $2.003M
Prepaid Expenses
Receivables $21.48M $19.26M
Other Receivables $0.00 $0.00
Total Short-Term Assets $57.33M $28.15M
YoY Change 103.68% 24.0%
LONG-TERM ASSETS
Property, Plant & Equipment $16.64M $11.47M
YoY Change 45.05% 43.4%
Goodwill $2.929M
YoY Change
Intangibles $2.521M
YoY Change
Long-Term Investments
YoY Change
Other Assets $139.0K $179.0K
YoY Change -22.35% 79.0%
Total Long-Term Assets $23.83M $14.17M
YoY Change 68.13% 30.02%
TOTAL ASSETS
Total Short-Term Assets $57.33M $28.15M
Total Long-Term Assets $23.83M $14.17M
Total Assets $81.16M $42.32M
YoY Change 91.78% 25.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.465M $4.701M
YoY Change 16.25% 62.1%
Accrued Expenses $4.600M $461.0K
YoY Change 897.83% -82.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $4.900M
YoY Change -100.0% 16.67%
Long-Term Debt Due $3.800M $3.000M
YoY Change 26.67% 30.43%
Total Short-Term Liabilities $13.86M $15.23M
YoY Change -9.01% 27.96%
LONG-TERM LIABILITIES
Long-Term Debt $6.300M $4.000M
YoY Change 57.5% 42.86%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $7.148M $4.597M
YoY Change 55.49% 64.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.86M $15.23M
Total Long-Term Liabilities $7.148M $4.597M
Total Liabilities $21.00M $19.82M
YoY Change 5.95% 33.95%
SHAREHOLDERS EQUITY
Retained Earnings -$20.17M -$20.44M
YoY Change -1.31%
Common Stock $80.32M $42.93M
YoY Change 87.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $60.16M $22.50M
YoY Change
Total Liabilities & Shareholders Equity $81.16M $42.32M
YoY Change 91.78% 25.95%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$761.0K $102.0K
YoY Change -846.08% 3300.0%
Depreciation, Depletion And Amortization $1.586M $1.151M
YoY Change 37.79% 16.26%
Cash From Operating Activities -$790.0K $1.030M
YoY Change -176.7% -177.44%
INVESTING ACTIVITIES
Capital Expenditures $842.0K $883.0K
YoY Change -4.64% 269.46%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$840.0K -$880.0K
YoY Change -4.55% 266.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -810.0K 410.0K
YoY Change -297.56% -90.53%
NET CHANGE
Cash From Operating Activities -790.0K 1.030M
Cash From Investing Activities -840.0K -880.0K
Cash From Financing Activities -810.0K 410.0K
Net Change In Cash -2.440M 560.0K
YoY Change -535.71% -79.71%
FREE CASH FLOW
Cash From Operating Activities -$790.0K $1.030M
Capital Expenditures $842.0K $883.0K
Free Cash Flow -$1.632M $147.0K
YoY Change -1210.2% -109.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
60368672 shares
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5385000
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60335279 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60335279 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.08
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.44
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.48
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
650000 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3995221 shares
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21406000
CY2015Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1237000
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13855000
CY2015Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
6327000
CY2015Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7148000
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
60000
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5465000
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20167000
CY2015Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
821000
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
80262000
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
60155000
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81158000
CY2015Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
793000
CY2015Q1 us-gaap Liabilities
Liabilities
21003000
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3394000
CY2015Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3759000
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4079000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31248000
CY2015Q1 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
821000
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
900000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
371000
CY2015Q1 us-gaap Goodwill
Goodwill
2929000
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16640000
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1183000
CY2015Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4119000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
371000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1986000
CY2015Q1 us-gaap Assets
Assets
81158000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
371000
CY2015Q1 us-gaap Inventory Net
InventoryNet
2595000
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21484000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
371000
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
139000
CY2015Q1 us-gaap Assets Current
AssetsCurrent
57331000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
278000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
371000
CY2015Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4912000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4834000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60242818 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60242818 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.04
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4012096 shares
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19822000
CY2014Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1208000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14623000
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
5257000
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
6078000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
60000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6294000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19406000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
821000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
79751000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
60405000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81106000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
700000
CY2014Q4 us-gaap Liabilities
Liabilities
20701000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3897000
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3224000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4180000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33689000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
821000
CY2014Q4 us-gaap Goodwill
Goodwill
2929000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15082000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1141000
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4212000
CY2014Q4 us-gaap Assets
Assets
81106000
CY2014Q4 us-gaap Inventory Net
InventoryNet
2616000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20475000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1025000
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
12000
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4912000
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
141000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
58742000
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53469000 shares
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49277000 shares
CY2014Q1 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
41200000
CY2014Q1 us-gaap Gross Profit
GrossProfit
8709000
CY2014Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
25000
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-298000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
129000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
394000
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-265000
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
159000
CY2014Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
772000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
883000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
102000
CY2014Q1 us-gaap Interest Paid
InterestPaid
254000
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1492000
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
18182000
CY2014Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-192000
CY2014Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1693000
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
89000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
8315000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
628000
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2633000
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
884000
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
56000
CY2014Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1151000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
551000
CY2014Q1 us-gaap Cost Of Services
CostOfServices
9473000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-883000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
409000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5054000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-237000
CY2014Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
598000
CY2014Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
583000
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
89000
CY2014Q1 neo Increase Decrease In Warrant Expense
IncreaseDecreaseInWarrantExpense
-5000
CY2014Q1 neo Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
23018000
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.48
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
NEOGENOMICS INC
CY2015Q1 dei Trading Symbol
TradingSymbol
NEO
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-787000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
51000 shares
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
2742996 shares
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1610000
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60277000 shares
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
67875 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60277000 shares
CY2015Q1 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
53631000
CY2015Q1 us-gaap Gross Profit
GrossProfit
9544000
CY2015Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1000
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-21000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-756000
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.10
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001077183
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-561000
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-195000
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
5000
CY2015Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
921000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
842000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-761000
CY2015Q1 us-gaap Interest Paid
InterestPaid
212000
CY2015Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
23026000
CY2015Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
42000
CY2015Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
2525000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
342000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
10105000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
669000
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2914000
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
602000
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
93000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2441000
CY2015Q1 us-gaap Cost Of Services
CostOfServices
13482000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1586000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-812000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-842000
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6522000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-1078000
CY2015Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
109000
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
342000
CY2015Q1 neo Increase Decrease In Warrant Expense
IncreaseDecreaseInWarrantExpense
59000
CY2015Q1 neo Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
30605000

Files In Submission

Name View Source Status
0001193125-15-181991-index-headers.html Edgar Link pending
0001193125-15-181991-index.html Edgar Link pending
0001193125-15-181991.txt Edgar Link pending
0001193125-15-181991-xbrl.zip Edgar Link pending
d902771d10q.htm Edgar Link pending
d902771dex311.htm Edgar Link pending
d902771dex312.htm Edgar Link pending
d902771dex313.htm Edgar Link pending
d902771dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
neo-20150331.xml Edgar Link completed
neo-20150331.xsd Edgar Link pending
neo-20150331_cal.xml Edgar Link unprocessable
neo-20150331_def.xml Edgar Link unprocessable
neo-20150331_lab.xml Edgar Link unprocessable
neo-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending